AU500250B2 - Influenza vaccine - Google Patents
Influenza vaccineInfo
- Publication number
- AU500250B2 AU500250B2 AU77305/75A AU7730575A AU500250B2 AU 500250 B2 AU500250 B2 AU 500250B2 AU 77305/75 A AU77305/75 A AU 77305/75A AU 7730575 A AU7730575 A AU 7730575A AU 500250 B2 AU500250 B2 AU 500250B2
- Authority
- AU
- Australia
- Prior art keywords
- influenza vaccine
- influenza
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960003971 influenza vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GHGH447/74 | 1974-01-14 | ||
| CH44774A CH589453A5 (US08066781-20111129-C00013.png) | 1974-01-14 | 1974-01-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU7730575A AU7730575A (en) | 1976-07-15 |
| AU500250B2 true AU500250B2 (en) | 1979-05-17 |
Family
ID=4187233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU77305/75A Expired AU500250B2 (en) | 1974-01-14 | 1975-01-14 | Influenza vaccine |
Country Status (27)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2829089A1 (de) * | 1977-07-13 | 1979-02-01 | Sandoz Ag | Subunit-vakzine |
| JPH0688911B2 (ja) * | 1985-06-06 | 1994-11-09 | 国立予防衛生研究所長 | インフルエンザワクチン及びその製造方法 |
| TW570803B (en) * | 1997-04-09 | 2004-01-11 | Duphar Int Res | Influenza vaccine |
| EP0919243A1 (en) | 1997-11-25 | 1999-06-02 | Duphar International Research B.V | Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant |
| DE19938767C2 (de) * | 1999-08-16 | 2002-10-24 | Tad Pharma Gmbh | Spaltimpfstoffe |
| NZ567817A (en) * | 2005-11-01 | 2012-01-12 | Novartis Vaccines & Diagnostic | Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment |
| SI2192917T1 (sl) * | 2007-08-28 | 2014-05-30 | Baxter International Inc. | Postopek za proizvodnjo virusnih cepiv |
| WO2015071177A1 (en) | 2013-11-15 | 2015-05-21 | Novartis Ag | Removal of residual cell culture impurities |
-
1974
- 1974-01-14 CH CH44774A patent/CH589453A5/xx not_active IP Right Cessation
-
1975
- 1975-01-06 DK DK1475AA patent/DK140003B/da not_active IP Right Cessation
- 1975-01-06 FI FI750014A patent/FI54053C/fi not_active IP Right Cessation
- 1975-01-06 NO NO750031A patent/NO143128C/no unknown
- 1975-01-07 SE SE7500130A patent/SE427238B/xx not_active IP Right Cessation
- 1975-01-10 NL NL7500301.A patent/NL166622C/xx not_active IP Right Cessation
- 1975-01-10 DE DE2500785A patent/DE2500785B2/de active Granted
- 1975-01-13 GB GB1290/75A patent/GB1498261A/en not_active Expired
- 1975-01-13 PH PH16702A patent/PH14458A/en unknown
- 1975-01-13 DD DD183614A patent/DD116239A5/xx unknown
- 1975-01-13 IE IE59/75A patent/IE40794B1/xx unknown
- 1975-01-13 AT AT21475A patent/AT345449B/de not_active IP Right Cessation
- 1975-01-13 YU YU58/75A patent/YU41289B/xx unknown
- 1975-01-13 PL PL1975177303A patent/PL93689B1/pl unknown
- 1975-01-13 ES ES433759A patent/ES433759A1/es not_active Expired
- 1975-01-13 HU HU75SA2736A patent/HU173920B/hu not_active IP Right Cessation
- 1975-01-13 CA CA217,790A patent/CA1049406A/en not_active Expired
- 1975-01-13 IL IL46426A patent/IL46426A/xx unknown
- 1975-01-14 ZA ZA00750259A patent/ZA75259B/xx unknown
- 1975-01-14 SU SU752101722A patent/SU616997A3/ru active
- 1975-01-14 CS CS75255A patent/CS191254B2/cs unknown
- 1975-01-14 BE BE152368A patent/BE824372A/xx not_active IP Right Cessation
- 1975-01-14 AU AU77305/75A patent/AU500250B2/en not_active Expired
- 1975-01-14 JP JP50006975A patent/JPS58407B2/ja not_active Expired
- 1975-01-14 FR FR7501007A patent/FR2257305B1/fr not_active Expired
-
1980
- 1980-10-09 HK HK563/80A patent/HK56380A/xx unknown
-
1981
- 1981-01-29 JP JP56012831A patent/JPS6035326B2/ja not_active Expired
- 1981-12-30 MY MY204/81A patent/MY8100204A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1027416A (en) | Wingfold configuration | |
| AU497398B2 (en) | Tetanus vaccine | |
| AU467292B2 (en) | Eye-bush | |
| AU500250B2 (en) | Influenza vaccine | |
| CA1034136A (en) | O-aminosulfonyglycolic anilides | |
| AU498810B2 (en) | Influenza vaccines | |
| AU503647B2 (en) | Antipregnancy vaccine | |
| SU565112A1 (ru) | Моментный гидроцилиндр | |
| AU497239B2 (en) | Parainfluenza virus vaccine | |
| AU494738B2 (en) | Virus subunit vaccine | |
| AU485538B2 (en) | Preparation ofa-6-deoxy-5-hydroxytetracycline | |
| AU490363B2 (en) | Scaffolding | |
| AU480112B2 (en) | Wingfold configuration | |
| AU489628B2 (en) | Cinnoline derivatives | |
| AU494543B2 (en) | Pharmaceutical formulations | |
| AU486500B2 (en) | Xeroradiographic member | |
| AU8054075A (en) | Preparation ofa-6-deoxy-5-hydroxytetracycline | |
| AU482524B2 (en) | Pyridoindoles | |
| AU463759B2 (en) | Cyclopentanediones | |
| AU482405B2 (en) | Seco-prostaglandins | |
| AU488320B2 (en) | Polycycloanilines | |
| AU482293B2 (en) | 7-methoxycephalosporins | |
| AU485075B2 (en) | 2-nitroimidazoles | |
| AU487605B2 (en) | Bulbholder | |
| AU489054B2 (en) | Thiadiazolylimidazolidones |